Anavex Life Sciences Corp (AVXL)

[Millstone]

Two important things occurred today, the significance of which I think is somewhat overlooked:

1. Data from a mid-March poster about A3-71 was presented today. That's a couple weeks after the fact.

2. New coverage initiated by FBR. These guys, formerly known as Friedman, Billings, Ramsey, have been around a long time and are IMO a step up from Maxim for sure.

So, what is the significance?

I think the press release about A3-71, being released now, was to prime the market in advance of more news. I think the coverage from FBR was timed to get in before the big news. FBR will be hoping to supplant Maxim and do a capital raise on better terms. Dr. Missling wants to partner for $ and a Phase II/III but that doesn't mean $ won't be needed for development of A3-71 and other programs.

I sense that the news is almost here.

Millstone